GlassScriptPhysician profile
James A Foote
NPI 1255372504
$39,029.25
in general payments reported to CMS, 2019-2025
14 companies · $2,399 in 2025
The $2,399 reported for 2025 was more than what 84% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,663 · 2020: $1,480 · 2021: $10K · 2022: $746 · 2023: $2,408 · 2024: $15K · 2025: $2,399.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $14K · Food and Beverage: $2,138 · Travel and Lodging: $2,022 · Education: $1,500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $14,000.00 |
| Food and Beverage | $2,138.05 |
| Travel and Lodging | $2,022.27 |
| Education | $1,500.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $15,327.24 | 2023-2025 | Titan Sgs, Titan Sgs Standard Gastric Stapler, Titan Sgs Bailout Chuck |
| Intuitive Surgical, INC. | $15,002.06 | 2020-2025 | Da Vinci Surgical System |
| W. L. Gore & Associates, INC. | $4,227.77 | 2019-2023 | Gore Synecor Biomaterial |
| Medical Device Business Services, INC. | $2,610.00 | 2019 | |
| Novo Nordisk INC | $616.03 | 2021-2023 | Wegovy |
| Ethicon US, LLC | $480.94 | 2019-2025 | Echelon Flex, Harmonic |
| Medtronic, INC. | $148.09 | 2022 | |
| Mesh Suture INC | $142.14 | 2025 | |
| Davol INC. | $131.84 | 2023 | Phasix Mesh |
| Ethicon INC. | $125.01 | 2025 | Monarch Platform |
| Baxter Healthcare | $117.80 | 2019 | |
| Heron Therapeutics, INC. | $41.00 | 2024 | Aponvie, Zynrelef |
| Standard Bariatrics, INC. | $38.27 | 2022 | |
| Phathom Pharmaceuticals, INC. | $21.06 | 2025 | Voquezna |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Foote listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.